Literature DB >> 12229887

Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression.

Oliver Bock, Jerome Schlué, Ulrich Lehmann, Reinhard von Wasielewski, Florian Länger, Hans Kreipe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12229887     DOI： 10.1182/blood-2002-06-1811

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Bone marrow expression and plasma concentration of basic fibroblast growth factor in patients with idiopathic thrombocytopenic purpura.

Authors:  Bora Son; Kyeong Seob Shin; Sook Young Bae; Soo-Young Yoon
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

2.  Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.

Authors:  Oliver Bock; Julia Höftmann; Katharina Theophile; Kais Hussein; Birgitt Wiese; Jerome Schlué; Hans Kreipe
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

3.  [Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia].

Authors:  H M Kvasnicka; J Thiele; P Staib; K Engels; S Kriener; A Schmitt-Graeff
Journal:  Pathologe       Date:  2004-03       Impact factor: 1.011

4.  Myelofibrosis: molecular and cell biological aspects.

Authors:  Hans Kreipe; Guntram Büsche; Oliver Bock; Kais Hussein
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.